PTP — Pentixapharm Holding AG Cashflow Statement
0.000.00%
- €44.51m
- €30.30m
- €6.82m
Annual cashflow statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2024 December 31st | |
|---|---|
| Period Length: | 41 W |
| Source: | ARS |
| Standards: | IFRS |
| Status: | Final |
| Net Income/Starting Line | -12.8 |
| Depreciation | |
| Deferred Taxes | |
| Non-Cash Items | -0.036 |
| Other Non-Cash Items | |
| Changes in Working Capital | -6.78 |
| Change in Accounts Receivable | |
| Change in Other Assets | |
| Change in Accounts Payable | |
| Cash from Operating Activities | -4.33 |
| Capital Expenditures | -0.001 |
| Purchase of Fixed Assets | |
| Other Investing Cash Flow Items | 8.24 |
| Acquisition of Business | |
| Other Investing Cash Flow | |
| Cash from Investing Activities | 8.24 |
| Financing Cash Flow Items | 19.3 |
| Other Financing Cash Flow | |
| Cash from Financing Activities | 19.3 |
| Beginning Cash Balance | |
| Ending Cash Balance | |
| Net Change in Cash | 23.2 |